CD8 ⍣ T cells in different activation states have been difficult to identify phenotypically. In this study we have investigated whether Mac-1 (CD11b) expression can be used as a criterion to distinguish between recently activated effector cells and memory cells belonging to the CD8 ⍣ T cell subset. Polyclonal virus-specific effector and memory CD8 ⍣ T cells from lymphocytic choriomeningitis-and vesicular stomatitis virus-infected mice were visualized through staining for intracellular IFN-γ or binding of MHC-peptide tetramers, and Mac-1 expression was evaluated. Naive T cells and most virus-specific memory CD8 ⍣ T cells express little or no Mac-1 independent of the virus model employed. In contrast, the majority of CD8 ⍣ T cells present during acute infection express a significant level of Mac-1 and, similarly, Mac-1 expression is found on secondary effectors generated in response to viral re-exposure. We therefore suggest that high Mac-1 expression defines a subset of circulating effector cells and that the presence of this marker on antigen-specific CD8 ⍣ T cells signifies recent activation.
Introduction
Based on their activation state T cells can be subdivided into recently activated and memory CD8 ϩ T cells. Mac-1 is a member of the β 2 -integrin family of adhesion molecules, naive, effector and memory subsets. Naive T cells are resting cells that have not yet encountered antigen, whereas effector which includes LFA-1 (CD11a), Mac-1 (CD11b) and p150,95 (CD11c) (9). Each of these cell surface molecules is a T cells are recently activated cells able to perform specialized functions with high efficiency and without further differentiheterodimer comprising a unique α subunit associated with the common β 2 chain (CD18). Mac-1 is expressed on monoation. Immunological memory is the capacity of the immune system to respond faster and more efficiently against an cytes, neutrophils, peritoneal B-1 cells, CD8 ϩ dendritic cells, NK cells and a subset of CD8 ϩ T cells (10-15). It functions antigen previously encountered by the host (1). The mechanisms underlying the accelerated secondary response appear in cellular adhesion, phagocytosis and extravasation, and it may play a role in chemotaxis (9,10). Mac-1 binds a diverse to be both an increased number of antigen-specific T cells and a qualitative change in T cells that have already been group of ligands, which include inactivated complement component C3b (iC3b), fibrinogen, coagulant factor X and primed by antigen contact (2-5) . Although functional assays to detect the effects of antigenic priming are well established, the intercellular adhesion molecule ICAM-1 (16-19).
The expression of Mac-1 on naive, activated and memory it has been difficult to identify memory T cells in phenotypic terms. One reason for this has been an inability to distinguish CD8 ϩ T cells is controversial. In one previous study it was reported that CD11b might be the best single marker available between recently activated effector T cells and memory T cells, as many cell-surface markers are shared between these for discriminating between naive and memory CD8 ϩ T cells (11). In contrast, Zimmermann et al. found that Mac-1 exprestwo functionally distinct subsets (6-9).
For this reason we wanted to see if it was possible to use sion becomes down-regulated when CD8 ϩ T cells enter the memory phase (6). The latter finding was obtained in the Mac-1 expression as a criterion to differentiate between murine lymphocytic choriomeningitis virus (LCMV) model and Flow cytometry is based on analysis of adoptively transferred CD8 ϩ T cells Staining of cells for flow cytometry was performed as previfrom TCR transgenic mice. Using contemporary techniques ously described (30,31). Briefly, 10 6 cells were stained with to visualize polyclonal antigen-specific T cells (20) (21) (22) , we directly labeled mAb for 20 min in the dark at 4°C and washed have re-evaluated Mac-1 expression on virus-specific effector 2 times. In the case of biotin-conjugated antibodies, cells and memory T cells. Two different virus models were applied:
were additionally incubated with streptavidin-TriColor (Caltag, LCMV and vesicular stomatitis virus (VSV) infection. IndependSan Francisco, CA). Finally, cells were washed and fixed with ent of the model system employed, our results reveal a clear 1% paraformaldehyde. For tetramer staining (32), splenocytes correlation between the level of Mac-1 expression and recent were first incubated with tetramers at a pretitrated optimal activation. Thus, Mac-1 expression on CD8 ϩ T cells may be concentration for 1 h at room temperature, followed by surface used as a marker to differentiate recently activated effector staining as described. The quality of the tetramer staining cells from resting memory cells.
was validated by the fact that the tetramers stained the same CD8 ϩ T cell subset in TCR 318 mice as did mAb for the Methods transgenic receptor. were fixed with 1% paraformaldehyde, permeabilized using pathogen-free conditions and sentinels were tested regularly saponin and stained with anti-IFN-γ. for unwanted infections according to FELASA standards; no Samples were analyzed using a Becton Dickinson unwanted infections were detected. Mice from outside (Mountain View, CA) FACSCalibur, and at least 10 4 monosources were always allowed to acclimatize for at least 1 nuclear cells were gated using a combination of low angle week before entering into an experiment; by that time the and side scatter to exclude dead cells and debris. Data animals were~7-8 weeks old.
analysis was conducted using CellQuest and results are presented as histograms or dot-plots. Representative plots Virus infection are presented; usually three mice per experimental group LCMV of the Traub strain (LCMV Traub) was produced, stored were analyzed individually and experiments were repeated and quantified as described previously (24) . LCMV of the at least once with similar results. Armstrong strain (LCMV Armstrong) was kindly provided by M. B. A. Oldstone (Scripps Clinic and Research Foundation, La Jolla, CA) (25) . Mice were infected using a volume of 0.3 Results ml i.v.; when inoculated by this route, LCMV induces a Mac-1 is not expressed on peptide-stimulated naive LCMV transient, immunizing infection (26, 27) . VSV (Indiana strain, GP33-41-specific T cells originally provided by K. Berg of this Institute) was also produced, stored and quantified as described previously One way to visualize antigen-specific T cells is to detect (28) . The virus dose was 10 6 p.f.u.; when given i.v., this dose IFN-γ-producing cells following in vitro stimulation with relevant is non-lethal to immunocompetent mice, but induces a potent peptide for 5-6 h. To ascertain that this method could be CD8 ϩ T cell response (28, 29) .
used reliably to our purpose, we first examined if this in vitro peptide stimulation of T cells per se had any effect on Mac-1 Cell preparations expression. For this reason we wanted to compare Mac-1 Single-cell suspensions of spleen and lymph node cells were expression on naive T cells that either had been stimulated obtained by pressing the organs through a fine steel mesh, with relevant antigen or not. To carry out this analysis, we and erythrocytes were lysed by 0.83% NH 4 Cl treatment.
required a sizeable population of naive, virus-specific T cells that could be identified by flow cytometry. This requirement mAb for flow cytometry was met through the use of cells from a mouse strain in which The following mAb were purchased from PharMingen (San 50-60% of the CD8 ϩ cells express a TCR directed against Diego, CA) as rat anti-mouse antibodies: FITC-and LCMV GP33-41 (23) . These peptide-specific cells which CyChrome-conjugated anti-CD8a (53-6.7, IgG2a), phycoerare naive by classical phenotypic markers (i.e. CD44 low/int Lythrin-(PE)-conjugated anti-V α 2 TCR (B20.1, IgG2a), PE-conselectin high ) can be identified by mAb against V α 2 and V α 8. (Fig. 1D) , suggesting that Mac-1 is to be found primarily were surface stained with CyChrome-conjugated anti-CD8a, PEon the most differentiated effector cells. that replicates extensively in several organs and induces a potent CD8 ϩ T cell response. BALB/c mice were infected with 4800 p.f.u. of LCMV Armstrong and on day 8 postinfection (p.i.), splenocytes were analyzed for co-expression ex vivo compared to non-stimulated TCR transgenic (CD8 ϩ V α 2 ϩ ) as well as naive irrelevant CD8 ϩ T cells of Mac-1 and intracellular IFN-γ following in vitro stimulation with LCMV NP118-126. As can be seen in Fig. 2 ., a high (CD8 ϩ V α 2 -). We found that neither subset expressed Mac-1 to a significant degree (Fig. 1A and B) . This result indicates frequency of NP118-126-specific CD8 ϩ was detected and more than two-thirds of these expressed high levels of Macthat brief stimulation through the TCR does not modulate Mac-1 expression. This conclusion has been further supported 1. Also CD8 ϩ T cells of other specificities were found to express Mac-1 at this time. However, this is to be expected by (i) the consistent observation that no matter the source of the responder population, in vitro peptide stimulation never as we have only focussed on a single, albeit immunodominant epitope. Notably, the frequency of Mac-1 cells is substantially induced any shift in the Mac-1 expression profile compared to unstimulated cells (not shown) and (ii) the low level of higher for NP118-126-specific cells than for the remaining CD8 ϩ T cells (about one-third), consistent with the immunoMac-1 expression on peptide-stimulated memory cells (see below). In contrast to the situation in uninfected TCR transdominance of this epitope in the LCMV-specific response in H-2 d mice. genic mice, most CD8 ϩ cells expressing the transgenic receptor are positive for IFN-γ (Fig. 1C) and about half of the Having validated our approach, the analysis was repeated, this time using C57BL/6 mice and LCMV Traub, and in this latter cells express Mac-1 (Fig. 1D) , if the mice are infected with LCMV 5 days prior to analysis. Furthermore, a correlation case splenocytes were harvested not only at the peak of the primary response (day 8 p.i.) but also twice during the memory between the cytokine level and Mac-1 expression seems to to define antigen-specific cells, similar patterns of Mac-1 expression were observed on effector and memory cells.
Finally, we evaluated Mac-1 expression on LCMV-specific T cells in the lymph nodes to see if there would be a difference in tissue distribution of CD8 ϩ Mac-1 ϩ T cells. Mice were infected with 200 p.f.u. of LCMV Traub, and lymph nodes were harvested 8 days and 13 months after infection. Cells were stimulated with GP33-41 and peptide-specific CD8 ϩ IFN-γ ϩ T cells were analyzed for Mac-1 expression (Fig.  5) . During the acute response, almost all of the lymph node effector T cells expressed significant levels of Mac-1 matching that of splenic CD8 ϩ effector T cells. Thirteen months after infection, when a sizeable subset of LCMV-specific CD8 ϩ had again resettled in the lymph nodes, Mac-1 expression on lymph node memory T cells was completely down-regulated, similarly to what was observed in the spleen.
Mac-1 expression on effector and memory VSV-specific CD8 ϩ T cells
To see if a similar pattern would be observed following infection with a different virus, mice were infected with VSV, and Mac-1 expression on primary effector cells and memory cells was studied. VSV is not a natural mouse pathogen and it replicates poorly in the spleen. However, a substantial population of virus-specific CD8 ϩ T cells is induced (29) . C57BL/6 mice were infected with 10 6 p.f.u. of VSV, and on day 40 p.i., during the memory phase, Mac-1 expression on remaining NP52-59-specific T cells was low with a few cells still expressing Mac-1 at significant levels. Thus, except for an accelerated kinetics, the basic pattern of Mac-1 expression phase (50 and 110 days p.i.). Cells were stimulated with on virus-specific CD8 ϩ T cells was the same as that observed LCMV GP33-41 for 5 h and LCMV-specific CD8 ϩ T cells were following LCMV infection. again visualized through detection of IFN-γ intracellularly (Fig. Mac-1 expression on re-stimulated memory T cells during 3). Mac-1 expression was clearly up-regulated on the majority secondary immunization of the virus-specific cells directed towards this epitope during the acute phase of infection (day 8 p.i.). On day 50 p.i.,
To further study the correlation between Mac-1 expression Mac-1 expression had substantially decreased on the majority and recent activation, BALB/c mice were immunized with a of GP33-41-specific CD8 ϩ T cells though a minor subset still low dose (200 p.f.u.) of LCMV Armstrong, and 6 months later seemed positive. At 110 days p.i., T cells of this specificity they were reinfected with a high dose of LCMV Traub (~5ϫ10 5 expressed little or no Mac-1. p.f.u.). Five days after rechallenge, spleens were harvested Down-regulation of Mac-1 in the memory phase was suband Mac-1 expression on LCMV-specific CD8 ϩ IFN-γ ϩ T cells sequently demonstrated to occur also in BALB/c mice (data was analyzed (Fig. 7) . Using this protocol for infection, not shown and see Fig. 7 ). Thus using two different strains of reactivation of LCMV-specific CD8 ϩ T cells-as evidenced LCMV as well as two different mouse strains and viral epitopes, by a 2-to 3-fold increase in the frequency of virus-specific we have found that naive and memory CD8 ϩ cells express cells-could be obtained. As evident from Fig. 6 , 25-45% of little Mac-1, whereas high expression is found on primary LCMV-specific (IFN-γ ϩ ) CD8 ϩ in rechallenged mice were effectors.
Mac-1 ϩ as compared to Ͻ8% in matched immune mice To exclude that the way in which antigen-specific cells (P Ͻ 0.05, four or five mice per group). Thus reactivation of were defined (i.e. producers of IFN-γ) introduced a bias in virus-specific CD8 ϩ T cells was associated with reappearance the phenotypic profile, a similar analysis was carried out using of a Mac-1 ϩ subset. The fact that the number of Mac-1 ϩ H-2D b -GP33-41 tetramers to reveal antigen-specific CD8 ϩ CD8 ϩ T cells was never as high following rechallenge as cells. Similar kinetics of Mac-1 expression was observed (Fig. during primary infection is consistent with previous results on cytotoxic T lymphocyte (CTL) activity induced during primary 4), demonstrating that independent of the method chosen sequent results reveal that like naive T cells, most virusspecific CD8 ϩ T cells expressed little or no Mac-1 during the memory phase. On recently activated CD8 ϩ T cells, on the other hand, we found a significant up-regulation of Mac-1. Since it might be argued that not all virus-specific CD8 ϩ T cells would produce IFN-γ and therefore the obtained data would not hold true for all CD8 ϩ effectors, we also used MHC-peptide tetramers to visualize antigen-specific cells. As there is no known bias in the type of effectors detected using tetramers, this approach would provide an independent means of analyzing antigen-specific CD8 ϩ T cells. Analogous results were obtained, confirming that the phenotypes of memory and primary effectors were different. This result contradicts the claim by McFarland et al. that Mac-1 expression can be used to discriminate between naive and memory T cells (11). The latter suggestion was based on functional results, which showed that LCMV-immune splenocytes depleted of Mac-1 ϩ cells failed to mount a secondary virusspecific memory CTL response in vitro (11). The reason for the discrepancy is not clear. However, as our method is a more direct way of detecting Mac-1 ϩ expression on virusspecific T cells, we find that explanations other than expression of Mac-1 on memory CTL precursors must be invoked to account for the failure to generate a secondary CTL very different, with CD8 ϩ effector T cells being pivotal for control of the LCMV infection, whereas antibodies are central to protection from VSV-induced encephalitis (28, 34) . Despite these differences, our analysis revealed that following both and secondary LCMV infection, and probably reflects that the accelerated T cell response together with antiviral antibodies viral infections, a high frequency of virus-specific CD8 ϩ T cells present during the primary response expressed Mac-1, rapidly reduces the take of the secondary challenge dose (33).
whereas virus-specific CD8 ϩ T cells detected in the memory phase were predominantly Mac-1 low/-. Accordingly the Discussion observed pattern of Mac-1 expression is not specific to the LCMV infection. Contradictory results have been reported concerning Mac-1 expression on naive T cells, recently activated effector T cells
Rechallenge of immune mice led to reappearance of a subset of Mac-1 ϩ virus-specific CD8 ϩ T cells although this and memory T cells. In the present study we have re-evaluated Mac-1 expression on CD8 ϩ T cells as a function of activation subset is not quite as dominant during secondary infection. The explanation for this is probably that the accelerated state, by use of a technology that to our knowledge has not previously been applied in this context. Our primary approach immune response in immune mice rapidly controls the infection, thereby minimizing the antigenic load under these condiis based on detecting antigen-specific, IFN-γ-producing CD8 ϩ T cells following in vitro stimulation with the relevant peptide.
tions (33). Nevertheless, there is no doubt that reinfection leading to reactivation of virus-specific CD8 ϩ T cells (as To ascertain that this method could be used to our purpose, we first examined if in vitro stimulation of T cells in itself had evidenced by expansion of the virus-specific CD8 ϩ subset) is associated with a significant shift in Mac-1 profile. This any effect on Mac-1 expression. Mac-1 expression on in vitro stimulated T cells from TCR transgenic mice was compared finding, however, is in contrast to the results reported by McFarland et al., who find that secondary CD8 ϩ effectors with that of non-stimulated TCR transgenic T cells and naive irrelevant CD8 ϩ T cells. Neither comparison revealed generated through in vitro stimulation for 5 days do not express Mac-1 (11). One reason for this discrepancy could increased Mac-1 expression following brief in vitro stimulation. This finding together with the fact that in vitro stimulation with be that we induced the secondary response in vivo rather than in vitro. peptide consistently failed to induce changes in the overall Mac-1 profile of CD8 ϩ cells, no matter the responder populaOur observations agree well with the suggestion of Zimmermann et al., that Mac-1 expression is more closely tion tested, validates this experimental approach. Our sub-
